HCV Typing Probes via Multidimensional Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hepatitis C virus (HCV) diagnostic methods struggle to accurately differentiate between the increasing number of HCV genotypes and subtypes, and simultaneously determine viral load, which is crucial for effective treatment and epidemiological tracing.
Innovation Solution
The use of a multidimensional analysis with combinations of HCV typing probes that provide unique and complementary information to accurately differentiate at least five HCV types (genotypes or subtypes) and quantify viral load in a closed-tube system, employing asymmetric PCR and amplicon quantitation probes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional HCV diagnostic methods are used, then the testing process is simple, but the ability to differentiate between increasing number of HCV genotypes and subtypes is insufficient
Solution Approach 1:
The diagnostic method segments the HCV typing process into distinct functional components: asymmetric PCR amplification generates strand-specific amplicons, multiple probes with different melting temperatures detect different genotype regions, and stepwise temperature cycling separates hybridization events. This segmentation enables differentiation of multiple HCV genotypes and subtypes while maintaining a manageable procedural framework
Solution Approach 2:
The invention adds the temperature dimension to the diagnostic process by using stepwise temperature cycling during hybridization. Probes with different melting temperatures allow detection at different temperature steps, creating a temporal and thermal dimension that enables multiplexed genotype detection without increasing physical complexity of the assay format
2Productivity
If conventional HCV diagnostic methods are used, then the procedure is straightforward, but simultaneous determination of viral load is not achieved
Solution Approach 1:
The method merges genotyping and viral load quantitation into a single integrated assay. The asymmetric PCR reaction simultaneously generates amplicons for both genotype detection and quantitation, while the hybridization step with multiple probes performs both functions in parallel. This merging eliminates the need for separate testing procedures, doubling the productivity without proportionally increasing system complexity
Solution Approach 2:
The diagnostic system achieves multi-functionality where the same reagents and procedural steps serve dual purposes. The asymmetric PCR amplicons are used both for genotype identification through probe hybridization and for viral load quantitation through signal intensity measurement. This universality allows a single test to deliver both genotyping and quantitation results
3Measurement precision
If multiple HCV typing probes are used to differentiate more genotypes, then the typing accuracy improves, but the difficulty of detecting and measuring increases
Solution Approach 1:
The invention applies local quality by designing probes with specific local characteristics - each probe has a unique melting temperature optimized for detecting particular genotype regions. This local differentiation through temperature-specific probe design allows accurate typing of multiple genotypes while simplifying the overall measurement process, as probes are activated at different temperature steps rather than requiring simultaneous complex analysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the accuracy and robustness of HCV typing, overcoming the limitations of existing methods by providing simultaneous genotyping and quantitation, and is adaptable to new HCV types and quasispecies.
Implementation Method 1
hybridizing the amplicon with at least a first probe and a second probe, to form at least two target hybridization complexes
Implementation Method 2
hybridization complexes comprising said first probe and said nucleotide sequence have a distinguishing hybridization property that differentiates at least two HCV types
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to methods for modifying the emission of light from labeled nucleic acids for the purpose of real time detection, analysis, and quantitation of nucleic acid sequences, e.g., using singly labeled probes. These methods and reagents exploit advantageous properties of thiazine dyes and diazine dyes. Furthermore, the use of these soluable light emission modifiers in background reduction, nucleic acid duplex stabilization and other uses is also described. Related kits, reaction mixtures and integrated systems are described.